title: Reversible palpebral ptosis following oxaliplatin infusion.
authors.forename: N
authors.initials: N
authors.lastname: La Verde
authors.forename: M C
authors.initials: MC
authors.lastname: Garassino
authors.forename: G
authors.initials: G
authors.lastname: Spinelli
authors.forename: A
authors.initials: A
authors.lastname: Scanni
authors.forename: P
authors.initials: P
authors.lastname: Sburlati
authors.forename: G
authors.initials: G
authors.lastname: Farina
authors.forename: R
authors.initials: R
authors.lastname: Labianca
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001763:Blepharoptosis / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008875:Middle Aged; D020258:Neurotoxicity Syndromes / Q000209:etiology* / Q000503:physiopathology; D009944:Organoplatinum Compounds / Q000009:adverse effects*; D000077150:Oxaliplatin
chemical_list: D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin